KEGG: bta:787444
UniGene: Bt.66660
NKAIN2 belongs to a superfamily of transmembrane proteins that interact with the β1 subunits of Na+/K+-ATPase. The gene consists of eight coding exons spanning approximately 1 Mb of genomic DNA on chromosome 6q. Four main splice variants have been identified, including two short isoforms containing four exons and two long isoforms containing seven exons .
The NKAIN family shows striking evolutionary conservation among species, with particularly strong amino acid conservation in the first two transmembrane domains from Drosophila to human, indicating significant functional importance . The protein contains a DUF798 domain (Domain of Unknown Function), which is phylogenetically well conserved .
| Gene | Location | Expression | Involvement in diseases |
|---|---|---|---|
| NKAIN1 | 1p35.2 | Neuron-specific | Alcohol dependence |
| NKAIN2 | 6q22.31 | Neuron-specific | Genital herpes, alcohol dependence, lymphoma, neuroblastoma, prostate cancer, type 2 diabetes mellitus |
| NKAIN3 | 8q12.13 | Neuron-specific | - |
| NKAIN4 | 20q13.33 | Ubiquitous | - |
Table 1: Comparison of NKAIN family members characteristics
Escherichia coli (E. coli) is frequently used for the recombinant expression of NKAIN2 and similar proteins due to its established protocols, cost-effectiveness, and high yield. Based on findings from comparable recombinant protein studies, a prokaryotic expression system using E. coli can produce significant yields of soluble recombinant protein .
For optimal expression, consider the following methodological approach:
Clone the bovine NKAIN2 cDNA sequence into a suitable expression vector with an appropriate tag (such as GST, which has been successfully used for human NKAIN2)
Transform the construct into an E. coli strain optimized for recombinant protein expression (such as BL21(DE3))
Use experimental design approaches to optimize expression conditions:
In one study involving recombinant protein expression, researchers achieved high levels (250 mg/L) of soluble functional protein in E. coli through systematic optimization of process conditions .
Based on protocols for similar recombinant proteins, the following storage conditions are recommended:
Short-term storage: Store at 2-8°C for 1-2 weeks
Long-term storage: Aliquot and store at -20°C to -80°C for up to 3 months
For lyophilized protein: Reconstitute with sterile water and add an equal volume of glycerol
For optimal stability during lyophilization, the purified protein can be lyophilized from sterile PBS (58mM Na₂HPO₄, 17mM NaH₂PO₄, 68mM NaCl, pH 7.4) with 5% trehalose and 5% mannitol added as protectants .
When designing experiments to study bovine NKAIN2 function, a block design approach is particularly useful. This experimental paradigm consists of alternating task blocks with rest periods, which helps establish stable baseline measurements and improves statistical power .
Key methodological considerations:
Block Design Implementation:
Controls:
Randomization:
For example, when studying NKAIN2 interaction with Na+/K+-ATPase, researchers could design blocks of different experimental conditions (varying concentrations, presence of inhibitors, etc.) with rest periods in between to establish clear baseline measurements.
Experimental design methodology can significantly enhance recombinant protein expression. The following systematic approach is recommended:
Factorial Design Optimization:
Expression Vector and Tag Selection:
Solubility Enhancement:
Co-express with molecular chaperones if inclusion body formation is observed
Test various lysis buffers with different detergents for optimal extraction
Consider lowering induction temperature to 16-20°C to slow expression and improve folding
Following this approach, researchers have achieved high-level soluble expression (250 mg/L) of functional recombinant proteins in E. coli, which can be applied to bovine NKAIN2 expression .
In silico analysis is crucial for predicting protein structure, function, and properties before experimental validation. For recombinant bovine NKAIN2, consider the following methodological approaches:
Sequence Analysis:
Structural Prediction:
Use homology modeling to predict 3D structure based on known structures of related proteins
Apply tools like AlphaFold, SWISS-MODEL, or I-TASSER
Analyze predicted transmembrane domains and potential interaction sites with Na+/K+-ATPase
Function Prediction:
Identify potential post-translational modification sites
Predict protein-protein interaction motifs, particularly those involved in Na+/K+-ATPase binding
Analyze potential phosphorylation sites that might regulate protein function
When conducting in silico analysis, it's important to compare bovine NKAIN2 with the human ortholog, which shows specific interaction with the β1 subunit of Na+/K+-ATPase and has been implicated in nervous system development .
To validate the interaction between recombinant bovine NKAIN2 and Na⁺/K⁺-ATPase, multiple complementary approaches should be employed:
Co-immunoprecipitation (Co-IP):
Use anti-NKAIN2 antibodies to pull down the protein complex
Probe for Na⁺/K⁺-ATPase β1 subunit using Western blot
Include appropriate controls: IgG control, lysates from cells not expressing NKAIN2
Surface Plasmon Resonance (SPR):
Immobilize purified Na⁺/K⁺-ATPase on a sensor chip
Measure binding kinetics of recombinant bovine NKAIN2
Determine association (ka) and dissociation (kd) rate constants
Calculate equilibrium dissociation constant (KD)
Förster Resonance Energy Transfer (FRET):
Create fusion constructs of NKAIN2 and Na⁺/K⁺-ATPase with appropriate fluorophores
Measure energy transfer in live cells or in vitro
Quantify the interaction strength based on FRET efficiency
Functional Assays:
Measure Na⁺/K⁺-ATPase activity in the presence and absence of NKAIN2
Use enzyme activity assays to determine if NKAIN2 modulates ATPase function
Test various concentrations of NKAIN2 to establish dose-response relationships
These methodologies provide complementary evidence for protein-protein interactions, with each technique offering different advantages in terms of sensitivity, specificity, and physiological relevance.
To comprehensively analyze the tissue-specific expression patterns of bovine NKAIN2, a multi-method approach is recommended:
Quantitative PCR (qPCR):
Design primers specific to bovine NKAIN2 transcript variants
Isolate RNA from various bovine tissues
Perform qPCR using appropriate reference genes
Analyze differential expression across tissues
Immunohistochemistry (IHC):
Use validated antibodies against bovine NKAIN2
Perform IHC on tissue sections from various bovine organs
Include appropriate positive controls (known expression sites) and negative controls
Quantify expression levels using digital image analysis
Western Blot Analysis:
Prepare protein extracts from different bovine tissues
Perform Western blotting using antibodies against NKAIN2
Quantify relative protein expression levels
Compare with human expression patterns for evolutionary context
Based on human data, NKAIN2 shows neuron-specific expression and is abundantly expressed in brain tissues . In the Human Protein Atlas, NKAIN2 expression is particularly notable in the hippocampal formation, amygdala, basal ganglia, midbrain, and other brain regions . When investigating bovine tissues, focus particularly on nervous system tissues.
To investigate the potential tumor suppressor role of bovine NKAIN2, researchers should employ a comprehensive experimental approach:
Expression Analysis in Normal vs. Tumor Tissues:
Compare NKAIN2 expression levels in normal bovine tissues and tumor samples
Use qPCR, Western blot, and immunohistochemistry for comprehensive assessment
Analyze correlation between expression levels and tumor grade/stage if available
Functional Studies:
Use CRISPR-Cas9 to knock out NKAIN2 in bovine cell lines
Overexpress NKAIN2 in bovine tumor cell lines with low endogenous expression
Assess effects on:
Cell proliferation
Apoptosis
Migration and invasion
Colony formation
Mechanistic Studies:
Identify potential downstream effectors through RNA-seq or proteomics
Investigate signaling pathways potentially regulated by NKAIN2
Examine potential roles in cell cycle regulation
In human studies, NKAIN2 has been found to be truncated in prostate cancer and deleted in castration-resistant prostate cancer (CRPC) . Inactivation of NKAIN2 appears at the early stage of developing castration resistance. NKAIN2 is also downregulated in human brain and CNS cancers . These findings suggest that NKAIN2 may function as a tumor suppressor in multiple contexts, which could be explored in bovine systems as well.
When faced with contradictory findings about NKAIN2 function, researchers should employ a systematic analytical approach:
Context-Dependent Analysis:
NKAIN2 may have tissue-specific roles—functioning as a tumor suppressor in some contexts while promoting cell growth in others
In neuronal tissues, NKAIN2 appears to be required for cell proliferation, with elevated expression detected in neuroblastoma
In prostate and other tissues, NKAIN2 appears to function as a tumor suppressor
Methodological Comparison:
Analyze differences in experimental methods that might explain contradictory results
Consider variations in:
Expression systems (prokaryotic vs. eukaryotic)
Cell types used (primary cells vs. cell lines)
Protein tags and their potential interference with function
Assay conditions and sensitivity
Isoform-Specific Function:
Species-Specific Differences:
Compare bovine and human NKAIN2 sequences to identify potential functional differences
Consider evolutionary conservation of specific domains versus species-specific adaptations
When evaluating contradictory findings, consider the biological context carefully. For example, Romania et al. found that NKAIN2 was expressed at high mRNA levels in neuroblastoma patients and detected in MYCN-amplified neuroblastoma cell lines, suggesting a potential oncogenic role in neuronal contexts . In contrast, NKAIN2 appears to act as a tumor suppressor in prostate cancer and other tissues .
For comprehensive bioinformatic analysis of bovine NKAIN2, implement the following methodological framework:
Evolutionary Conservation Analysis:
Use tools like ConSurf to map conservation scores onto protein structure
Perform multiple sequence alignment across species to identify highly conserved regions
Generate phylogenetic trees to understand evolutionary relationships of NKAIN proteins
Structural Domain Analysis:
Protein-Protein Interaction Prediction:
Use tools like STRING, PSICQUIC, and IntAct to predict interaction partners
Focus on Na+/K+-ATPase β1 subunit interactions
Identify potential binding motifs and interfaces
Molecular Dynamics Simulations:
Build 3D models using homology modeling or ab initio prediction methods
Perform molecular dynamics simulations to understand protein flexibility and stability
Analyze potential conformational changes upon binding to interaction partners
When analyzing sequence conservation, note that NKAIN genes show striking evolutionary conservation among species, particularly in the first two transmembrane domains from Drosophila to human . This high conservation suggests functional significance in these regions. For bovine NKAIN2, compare with the human sequence (UniProt ID: Q5VXU1) to identify potential functional differences .
Designing effective antibodies for bovine NKAIN2 requires careful consideration of several methodological factors:
Epitope Selection:
Choose epitopes unique to NKAIN2 (avoid regions with similarity to other NKAIN family members)
Target regions that are:
Highly antigenic (use tools like BepiPred, ABCpred)
Surface-exposed (based on structural predictions)
Conserved between bovine and model species (if using for cross-species studies)
Outside the transmembrane domains (for better accessibility)
Antibody Format Selection:
Polyclonal antibodies: Provide broader epitope recognition but may have batch-to-batch variation
Monoclonal antibodies: Offer high specificity and consistency but may have limited epitope recognition
Recombinant antibodies: Allow for precise engineering but may require more development
Validation Strategy:
Test antibody against:
Purified recombinant bovine NKAIN2
Positive control tissues (based on expression data)
Negative control tissues (with no NKAIN2 expression)
NKAIN2 knockout or knockdown samples
Perform cross-reactivity tests with other NKAIN family members
Application-Specific Considerations:
For Western blotting: Target linear epitopes
For immunoprecipitation: Target surface-exposed regions
For immunohistochemistry: Consider fixation effects on epitope accessibility
When designing antibodies, note that bovine NKAIN2 is expected to be primarily expressed in nervous system tissues, similar to human NKAIN2 . The protein contains multiple transmembrane domains, so careful epitope selection is crucial for generating antibodies that can recognize the native protein in different experimental contexts.
To quantitatively characterize the interaction between bovine NKAIN2 and Na⁺/K⁺-ATPase, implement these methodological approaches:
Microscale Thermophoresis (MST):
Label one protein (preferably the smaller one) with a fluorescent dye
Prepare serial dilutions of the unlabeled binding partner
Measure changes in thermophoretic mobility upon binding
Calculate binding constants (KD) from concentration-dependent changes
Isothermal Titration Calorimetry (ITC):
Directly measure thermodynamic parameters of binding
Determine:
Binding affinity (KD)
Binding stoichiometry (n)
Enthalpy changes (ΔH)
Entropy changes (ΔS)
No labeling required, providing label-free quantification
Bio-Layer Interferometry (BLI):
Immobilize one protein on a biosensor tip
Measure real-time binding of the interaction partner
Determine association and dissociation rates
Calculate affinity constants from kinetic data
Quantitative FRET Analysis:
Create fusion constructs with appropriate fluorophore pairs
Measure FRET efficiency at various concentration ratios
Apply mathematical models to extract binding parameters
Particularly useful for membrane protein interactions
Data Analysis and Validation:
Fit binding data to appropriate models (1:1 binding, cooperative binding, etc.)
Use global fitting across multiple experiments to improve parameter estimation
Validate results using multiple independent methods
Test effects of mutations at predicted interaction interfaces
These quantitative approaches provide comprehensive characterization of protein-protein interactions, offering insights into the strength, kinetics, and thermodynamics of the bovine NKAIN2 interaction with Na⁺/K⁺-ATPase.
Researchers face several significant challenges when studying bovine NKAIN2:
Protein Expression and Purification:
Challenge: NKAIN2 is a transmembrane protein, which typically presents difficulties in expression and purification
Solution:
Use specialized detergents for extraction
Consider nanodiscs or styrene maleic acid lipid particles (SMALPs) for membrane protein studies
Explore insect cell or mammalian expression systems for proper folding and post-translational modifications
Limited Available Resources:
Challenge: Few validated reagents specific for bovine NKAIN2 are commercially available
Solution:
Generate custom antibodies using recombinant proteins as immunogens
Validate commercial antibodies raised against human NKAIN2 for cross-reactivity
Develop bovine-specific molecular tools (plasmids, CRISPR guides, etc.)
Complex Isoform Pattern:
Tissue-Specific Expression:
Challenge: Primarily expressed in neuronal tissues, which can be difficult to obtain and work with
Solution:
Establish collaborations with veterinary schools for tissue access
Consider organoid models to recapitulate tissue-specific environments
Use conditional expression systems in heterologous cell lines
Addressing these challenges requires interdisciplinary approaches combining molecular biology, biochemistry, structural biology, and computational methods.
Several cutting-edge technologies hold promise for advancing NKAIN2 research:
Cryo-Electron Microscopy (Cryo-EM):
Application: Determine high-resolution structures of NKAIN2 alone and in complex with Na+/K+-ATPase
Advantage: Works well for membrane proteins without crystallization
Expected insight: Molecular details of NKAIN2-Na+/K+-ATPase interaction interface
Single-Cell RNA Sequencing (scRNA-seq):
Application: Profile NKAIN2 expression across different cell types in bovine tissues
Advantage: Reveals cell-type specific expression patterns not detectable in bulk analysis
Expected insight: Identification of specific neuronal populations expressing NKAIN2
CRISPR-Cas9 Genome Editing:
Application: Create precise modifications in the bovine NKAIN2 gene
Advantage: Generate knockout, knockin, and point mutations in relevant cell lines
Expected insight: Functional consequences of NKAIN2 loss or mutation
Proximity Labeling (BioID, APEX):
Application: Identify proteins that interact with NKAIN2 in living cells
Advantage: Captures weak or transient interactions in native cellular environment
Expected insight: Comprehensive NKAIN2 interactome beyond Na+/K+-ATPase
Organoids and Organ-on-a-Chip:
Application: Study NKAIN2 function in more physiologically relevant contexts
Advantage: Recapitulates tissue architecture and cellular heterogeneity
Expected insight: Role of NKAIN2 in complex tissue environments
These technologies, especially when used in combination, can provide unprecedented insights into bovine NKAIN2 structure, function, interaction partners, and tissue-specific roles.